Roche P - Search Results

1

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M, Kenyon K, Davis MM, Riddell SR, Greenberg PD. Yee C, et al. Among authors: roche p. J Exp Med. 2000 Dec 4;192(11):1637-44. doi: 10.1084/jem.192.11.1637. J Exp Med. 2000. PMID: 11104805 Free PMC article.

2

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.

Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, Greenberg PD. Yee C, et al. Among authors: roche p. Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16168-73. doi: 10.1073/pnas.242600099. Epub 2002 Nov 11. Proc Natl Acad Sci U S A. 2002. PMID: 12427970 Free PMC article. Clinical Trial.

3

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.

Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L. Dong H, et al. Nat Med. 2002 Aug;8(8):793-800. doi: 10.1038/nm730. Epub 2002 Jun 24. Nat Med. 2002. PMID: 12091876

4

Transcriptional complementarity in breast cancer: application to detection of circulating tumor cells.

Houghton RL, Dillon DC, Molesh DA, Zehentner BK, Xu J, Jiang J, Schmidt C, Frudakis A, Repasky E, Maltez Filho A, Nolasco M, Badaro R, Zhang X, Roche PC, Persing DH, Reed SG. Houghton RL, et al. Among authors: roche pc. Mol Diagn. 2001 Jun;6(2):79-91. doi: 10.1007/BF03262038. Mol Diagn. 2001. PMID: 11468693

5

Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma.

Weinman EC, Roche PC, Kasperbauer JL, Cha SS, Sargent DJ, Cheville J, Murphy LM, Chen L, Wettstein PJ, Gostout B, Ferrone S, Strome SE. Weinman EC, et al. Cancer. 2003 May 1;97(9):2203-11. doi: 10.1002/cncr.11311. Cancer. 2003. PMID: 12712472 Free article.

6

Her-2/neu expression in ovarian cancer: pre- and postexposure to platinum chemotherapy.

Peethambaram PP, Cliby WA, Lubiniecki G, Clayton AC, Roche PC, Iturria SJ, Hartmann LC, Hellström I, Strome SE. Peethambaram PP, et al. Among authors: roche pc. Gynecol Oncol. 2003 Apr;89(1):99-104. doi: 10.1016/s0090-8258(03)00065-9. Gynecol Oncol. 2003. PMID: 12694661

7

Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma.

Kienstra MA, Neel HB, Strome SE, Roche P. Kienstra MA, et al. Among authors: roche p. Head Neck. 2003 Jun;25(6):457-63. doi: 10.1002/hed.10223. Head Neck. 2003. PMID: 12784237

8

In vivo analysis of Fas/FasL interactions in HIV-infected patients.

Badley AD, Dockrell DH, Algeciras A, Ziesmer S, Landay A, Lederman MM, Connick E, Kessler H, Kuritzkes D, Lynch DH, Roche P, Yagita H, Paya CV. Badley AD, et al. Among authors: roche p. J Clin Invest. 1998 Jul 1;102(1):79-87. doi: 10.1172/JCI2691. J Clin Invest. 1998. PMID: 9649560 Free PMC article.

9

The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection.

Dockrell DH, Badley AD, Villacian JS, Heppelmann CJ, Algeciras A, Ziesmer S, Yagita H, Lynch DH, Roche PC, Leibson PJ, Paya CV. Dockrell DH, et al. Among authors: roche pc. J Clin Invest. 1998 Jun 1;101(11):2394-405. doi: 10.1172/JCI1171. J Clin Invest. 1998. PMID: 9616211 Free PMC article.

10

MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumors.

Cheville JC, Roche PC. Cheville JC, et al. Among authors: roche pc. Mod Pathol. 1999 Oct;12(10):974-8. Mod Pathol. 1999. PMID: 10530563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

895 results

Search Page

Filters